FRAMINGHAM, Massachusetts—Alira Health, a global health care advisory, clinical research and technology company, announces the spin-off of ProDevLabs, a new company led by Mitchell Sanders, Ph.D., a former Alira Health executive.
ProDevLabs will continue its work as a product development lab focused on chronic inflammatory diseases, including wound care, cancer, infections/biofilms and neuropathologies such as traumatic brain injury, Alzheimer’s and Parkinson’s.
“Dr. Sanders is a visionary scientist who launched this product development lab at Alira Health in 2015,” said Gabriele Brambilla, CEO and co-founder of Alira Health. “It’s been a pleasure working with Mitch and nurturing the growth of the lab to become a successful business.”
“ProDevLabs will continue its growth trajectory as a best-in-class CRO,” said Sanders. “We plan to add new talent and resources to accommodate our clients’ needs. I am grateful to Alira Health for the opportunity to grow these services over the last eight years and look forward to maintaining our close relationship with Alira Health.”
